Citation Impact
Citing Papers
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
2007 StandoutScience
MutL traps MutS at a DNA mismatch
2015 StandoutNobel
Hypermethylation of ASC/TMS1 Is a Sputum Marker for Late-Stage Lung Cancer
2006
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
2004 StandoutScience
Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma
2012
Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death
2000
Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives
2013
Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma
2007
Hallmarks of Cancer: The Next Generation
2011 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
How chemokines organize the tumour microenvironment
2023
Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status
2001
Myeloid-derived suppressor cells coming of age
2018 Standout
Microsatellite Instability in Colorectal Cancer
2010 Standout
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
2017
The biology and management of non-small cell lung cancer
2018 StandoutNature
Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection
1998
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
Lung Cancer
2008 Standout
Unlocking Biomarker Discovery: Large Scale Application of Aptamer Proteomic Technology for Early Detection of Lung Cancer
2010
Hepatocellular adenoma: Classification, variants and clinical relevance
2016
Macrophages, innate immunity and cancer: balance, tolerance, and diversity
2010
Focus on hepatocellular carcinoma
2004
Characterization of Small Nodules in Cirrhosis by Assessment of Vascularity: The Problem of Hypovascular Hepatocellular Carcinoma *
2005
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Screening for hepatocellular carcinoma
1999
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Increased risk of hepatocellular carcinoma development in patients with cirrhosis and with high hepatocellular proliferation
1994
Hepatocellular carcinoma
2012 Standout
Resistance to ROS1 Inhibition Mediated by EGFR Pathway Activation in Non-Small Cell Lung Cancer
2013
A Molecular Signature to Discriminate Dysplastic Nodules From Early Hepatocellular Carcinoma in HCV Cirrhosis
2006
11q13 Allelic Imbalance Discriminates Pulmonary Carcinoids from Tumorlets
1999
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
2014 StandoutNature
Screening for hepatocellular carcinoma
2005
Proliferating cell nuclear antigen and Ki‐67 labeling in hepatocellular nodules: a comparative study
1999
Structural and functional features of central nervous system lymphatic vessels
2015 StandoutNature
Management of Hepatocellular Carcinoma *
2005 Standout
Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma
2015
The lymphatic vasculature in disease
2011
Inflammation and Colon Cancer
2010 Standout
Combined hepatocellular-cholangiocarcinoma: An update
2021
ErbBs in lung cancer
2008
Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis
1996
Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography
2004
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
2001 Standout
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
2004 Standout
Oncogenic Mutations Counteract Intrinsic Disorder in the EGFR Kinase and Promote Receptor Dimerization
2012 StandoutNobel
Immunity, Inflammation, and Cancer
2010 Standout
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
2006
Screening for hepatocellular carcinoma in cirrhosis
2003
Prospective Analysis of Risk Factors for Hepatocellular Carcinoma in Patients With Liver Cirrhosis
2003
Focal lesions in cirrhotic explant livers: Pathological evaluation and accuracy of pretransplantation imaging examinations
2002
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
2010 Standout
Macrophages are critical effectors of antibody therapies for cancer
2015
Management of HCC
2012
PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients
2008
Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma
2007
Hepatitis C and hepatocellular carcinoma
1997
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
2018 StandoutNobel
Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: Matched case-control study, pathological analysis, and pathogenetic hypothesis
1997
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
1992 StandoutNature
Hepatocellular proliferation and development of hepatocellular carcinoma: A case-control study in chronic hepatitis C
1998
The expression and regulation of DFNA5 in human hepatocellular carcinoma DFNA5 in hepatocellular carcinoma
2013
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
2015
Microenvironmental regulation of metastasis
2008 Standout
EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines
2008
Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension
1993 Standout
Angiogenesis in liver disease
2009
Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma
2008
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
1996 StandoutNobel
p53 regulation by post-translational modification and nuclear retention in response to diverse stresses
1999
High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity
2001
Overexpressed Id‐1 is associated with a high risk of hepatocellular carcinoma development in patients with cirrhosis without transcriptional repression of p16
2005
Survival and Recurrence After Liver Transplantation Versus Liver Resection for Hepatocellular Carcinoma
1998
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
NF-κB functions as a tumour promoter in inflammation-associated cancer
2004 StandoutNature
Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT
2012
Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibition
2017
Qualifying antibodies for image-based immune profiling and multiplexed tissue imaging
2019
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
DNA mismatch repair: Molecular mechanism, cancer, and ageing
2008
Cancer-related inflammation: Common themes and therapeutic opportunities
2011
Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance☆
2004
Hepatocellular carcinoma
2022 Standout
Functional and genetic deconstruction of the cellular origin in liver cancer
2015
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab
2007
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
2017 StandoutNature
PCNA function in the activation and strand direction of MutLα endonuclease in mismatch repair
2010 StandoutNobel
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis
2001
KRAS Mutations and Sensitivity to Epidermal Growth Factor Receptor Inhibitors in Colorectal Cancer: Practical Application of Patient Selection
2009
Phenotypic consequences of lung-specific inducible expression of FGF-3
2001 StandoutNobel
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
2013 Standout
Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non–Small-Cell Lung Cancer Harboring ROS1 Rearrangement
2017
Clinical Significance and Prognostic Relevance of Microsatellite Instability in Sporadic Colorectal Cancer Patients
2017
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Simplified Staging for Hepatocellular Carcinoma
2002
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Iterative in Situ Click Chemistry Assembles a Branched Capture Agent and Allosteric Inhibitor for Akt1
2011 StandoutNobel
Promoter Hypermethylation of Multiple Genes in Sputum Precedes Lung Cancer Incidence in a High-Risk Cohort
2006
Genetic Classification of Lung Adenocarcinoma Based on Array-Based Comparative Genomic Hybridization Analysis: Its Association with Clinicopathologic Features
2005
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
2008
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Hepatocellular Carcinoma: Novel Molecular Approaches for Diagnosis, Prognosis, and Therapy
2010
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Dynamic enhancement pattern of HCC smaller than 3 cm in diameter on gadoxetic acid‐enhanced MRI : comparison with multiphasic MDCT
2014
Surveillance for hepatocellular carcinoma
2014
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
The Mononuclear Molybdenum Enzymes
2014 Standout
Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene.
1989
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Simplified Staging for Hepatocellular Carcinoma
2002
Subpopulations of myeloid‐derived suppressor cells impair T cell responses through independent nitric oxide‐related pathways
2013
Somatic Mutations of Epidermal Growth Factor Receptor in Colorectal Carcinoma
2005
Predictors of the Response to Gefitinib in Refractory Non–Small Cell Lung Cancer
2005
MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression
2016
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Imaging Techniques for the Diagnosis of Hepatocellular Carcinoma
2015
Innate immunity, inflammation and tumour progression: double‐edged swords
2019
Works of Massimo Roncalli being referenced
Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer
2012
The Chemokine Receptor CX3CR1 Is Involved in the Neural Tropism and Malignant Behavior of Pancreatic Ductal Adenocarcinoma
2008
HER-2/Neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization, and immunohistochemistry.
2003
'Vascular profiles' of regenerative and dysplastic nodules [3] (multiple letters)
2000
M2 Macrophages Phagocytose Rituximab-Opsonized Leukemic Targets More Efficiently than M1 Cells In Vitro
2009
The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: Implications for diagnosis and classification
1999
Abnormal DNA content in liver‐cell dysplasia: A flow cytometric study
1989
Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: A prospective study
1995
Contrast-enhanced doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis
2001
Combined use of heat-shock protein 70 and glutamine synthetase is useful in the distinction of typical hepatocellular adenoma from atypical hepatocellular neoplasms and well-differentiated hepatocellular carcinoma
2016
An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers
2016
Intensified CHOP regimen in aggressive lymphomas:maximal dose intensity and dose density of doxorubicin and cyclophosphamide
2002
EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients
2007
A Randomized Study of Lung Cancer Screening with Spiral Computed Tomography
2009
K-ras and p16INK4Aalterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers
2003
The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6
2009
Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma
2011
A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition
2012
Human Aldehyde Oxidase 1 Interacts with ATP-binding Cassette Transporter-1 and Modulates its Activity in Hepatocytes
2007
Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma
2009
Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib (‘Iressa’, ZD1839) in non-small-cell lung cancer
2004
CD3+ cells at the invasive margin of deeply invading (pT3–T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study
2009
Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma
2002
Molecular Changes in Hepatocellular Dysplastic Nodules on Microdissected Liver Biopsies
2000
Lung cancer screening with spiral CT
2007
Role of the stromal-derived factor-1 (SDF-1)–CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma
2012
The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma
2008
Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis†
2007
Prediction of Survival in Stage I Lung Carcinoma Patients by Telomerase Function Evaluation
2002
Modulation of human T‐cell functions by reactive nitrogen species
2011
A morphometric study of liver cell dysplasia
1988
Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development
2003
Liver cell dysplasia and risk of hepatocellular carcinoma in cirrhosis: a preliminary report.
1991
Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis
2007
Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients
2008
Ultrasonography-detected macroregenerative nodules in cirrhosis: a prospective study
1997
Diagnosis of Hepatocellular Carcinoma in Cirrhosis by Dynamic Contrast Imaging: The Importance of Tumor Cell Differentiation
2010
Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma
2016
Advanced precancerous lesions in the liver
2013
Distribution of Endothelin-like Immunoreactivity and mRNA in the Developing and Adult Human Lung
1991
Abnormal p53 Expression in Lung Neuroendocrine Tumors Diagnostic and Prognostic Implications
1992
Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis
2014
p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma.
1995
Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients
2009
EGFR, HER2 and Kras as predictive factors for cetuximab sensitivity in colorectal cancer
2007
[Nodular hepatocellular lesions. Guidelines and minimal diagnostic criteria for gastrointestinal histopathological diagnosis. Gruppo Italiano Patologi dell'Apparato Digerente].
2000
Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma
2015
Reduced Likelihood of Metastases in Patients with Microsatellite-Unstable Colorectal Cancer
2007
Liver-cell dysplasia and hepatocellular carcinoma.
1992
Effect of increased MET gene copy number on survival of surgically resected non-small cell lung cancer (NSCLC) patients
2008
Occurrence and significance of tumor‐associated neutrophils in patients with colorectal cancer
2016
Abnormal p53 Expression in Lung Neuroendocrine Tumors Diagnostic and Prognostic Implications
1992
Liver cell dysplasia and hepatocellular carcinoma: a histoiogical and immunohistochemical study
1985
Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis.
1998
Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer
2017